A Prospective Phase II Trial of Neoadjuvant S-1 with Concurrent Hypofractionated Radiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma

A Prospective Phase II Trial of Neoadjuvant S-1 with Concurrent Hypofractionated Radiotherapy in... Ann Surg Oncol (2017) 24:2777–2784 DOI 10.1245/s10434-017-5921-4 OR IG INA L A R TIC L E – PA NC REATIC TU MO RS A Prospective Phase II Trial of Neoadjuvant S-1 with Concurrent Hypofractionated Radiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 1 1 1 1 Keiichi Okano, MD, PhD, FACS , Hironobu Suto, MD , Minoru Oshima, MD, PhD , Eri Maeda, MD , 1 1 2 Naoki Yamamoto, MD, PhD , Keitaro Kakinoki, MD, PhD , Hideki Kamada, MD, PhD , Tsutomu Masaki, MD, 2 3 3 1 PhD , Shigeo Takahashi, MD , Toru Shibata, MD, PhD , and Yasuyuki Suzuki, MD, PhD Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University, Miki-cho, Kagawa, Japan; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Miki-cho, Kagawa, Japan; Department of Radiation Oncology, Faculty of Medicine, Kagawa University, Miki-cho, Kagawa, Japan ABSTRACT for Adverse Events (CTCAE) version 4.0] were anorexia Background. The ideal neoadjuvant treatment protocol (7%), nausea (5%), neutropenia (4%), and leukopenia for patients with pancreatic cancer (PDAC) remains (4%). No patient experienced grade 4 toxicity. Pathologi- unclear. We evaluated the efficacy and safety of neoadju- cally negative margins (R0) were achieved in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Surgical Oncology Springer Journals

A Prospective Phase II Trial of Neoadjuvant S-1 with Concurrent Hypofractionated Radiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma

Loading next page...
 
/lp/springer_journal/a-prospective-phase-ii-trial-of-neoadjuvant-s-1-with-concurrent-ZJafssfW0Z
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Society of Surgical Oncology
Subject
Medicine & Public Health; Surgical Oncology; Oncology; Surgery
ISSN
1068-9265
eISSN
1534-4681
D.O.I.
10.1245/s10434-017-5921-4
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial